JPH0195778A - Heat-resistant protease and its production - Google Patents
Heat-resistant protease and its productionInfo
- Publication number
- JPH0195778A JPH0195778A JP25374987A JP25374987A JPH0195778A JP H0195778 A JPH0195778 A JP H0195778A JP 25374987 A JP25374987 A JP 25374987A JP 25374987 A JP25374987 A JP 25374987A JP H0195778 A JPH0195778 A JP H0195778A
- Authority
- JP
- Japan
- Prior art keywords
- protease
- minutes
- heat
- activity
- bacillus stearothermophilus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108091005804 Peptidases Proteins 0.000 title claims abstract description 54
- 239000004365 Protease Substances 0.000 title claims abstract description 53
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 title claims abstract description 51
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 230000000694 effects Effects 0.000 claims abstract description 29
- 241000193385 Geobacillus stearothermophilus Species 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 239000000126 substance Substances 0.000 claims abstract description 7
- 238000002523 gelfiltration Methods 0.000 claims abstract description 6
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 6
- 238000012258 culturing Methods 0.000 claims abstract description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 230000002255 enzymatic effect Effects 0.000 claims abstract description 3
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 3
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 3
- 239000011701 zinc Substances 0.000 claims abstract description 3
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 claims abstract 2
- 239000000758 substrate Substances 0.000 claims description 15
- 150000001413 amino acids Chemical class 0.000 claims description 13
- 239000005018 casein Substances 0.000 claims description 10
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 10
- 235000021240 caseins Nutrition 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 6
- 229940071106 ethylenediaminetetraacetate Drugs 0.000 claims description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 6
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 claims description 5
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 5
- 238000000862 absorption spectrum Methods 0.000 claims description 4
- 239000003112 inhibitor Substances 0.000 claims description 4
- 102000004877 Insulin Human genes 0.000 claims description 3
- 108090001061 Insulin Proteins 0.000 claims description 3
- 238000000354 decomposition reaction Methods 0.000 claims description 3
- 229940125396 insulin Drugs 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 235000018102 proteins Nutrition 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 abstract description 2
- 102000004190 Enzymes Human genes 0.000 description 24
- 108090000790 Enzymes Proteins 0.000 description 24
- 229940088598 enzyme Drugs 0.000 description 24
- 108090001109 Thermolysin Proteins 0.000 description 12
- 239000000243 solution Substances 0.000 description 11
- 239000000872 buffer Substances 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 3
- 235000011130 ammonium sulphate Nutrition 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 230000002101 lytic effect Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- 108010053229 Lysyl endopeptidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- MUCZHBLJLSDCSD-UHFFFAOYSA-N diisopropyl fluorophosphate Chemical compound CC(C)OP(F)(=O)OC(C)C MUCZHBLJLSDCSD-UHFFFAOYSA-N 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000013882 gravy Nutrition 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- -1 inosit Chemical compound 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 230000002797 proteolythic effect Effects 0.000 description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 239000012089 stop solution Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108090000145 Bacillolysin Proteins 0.000 description 1
- 241000193389 Bacillus thermoproteolyticus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 101100074187 Caenorhabditis elegans lag-1 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- MMFKFJORZBJVNF-UWVGGRQHSA-N His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 MMFKFJORZBJVNF-UWVGGRQHSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QOOWRKBDDXQRHC-BQBZGAKWSA-N L-lysyl-L-alanine Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN QOOWRKBDDXQRHC-BQBZGAKWSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- MDSUKZSLOATHMH-IUCAKERBSA-N Leu-Val Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C([O-])=O MDSUKZSLOATHMH-IUCAKERBSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 101100261242 Mus musculus Trdmt1 gene Proteins 0.000 description 1
- MDSUKZSLOATHMH-UHFFFAOYSA-N N-L-leucyl-L-valine Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(O)=O MDSUKZSLOATHMH-UHFFFAOYSA-N 0.000 description 1
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 1
- 125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 101100426589 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) trp-3 gene Proteins 0.000 description 1
- 102000035092 Neutral proteases Human genes 0.000 description 1
- 108091005507 Neutral proteases Proteins 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- GKZIWHRNKRBEOH-HOTGVXAUSA-N Phe-Phe Chemical compound C([C@H]([NH3+])C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)C1=CC=CC=C1 GKZIWHRNKRBEOH-HOTGVXAUSA-N 0.000 description 1
- FSXRLASFHBWESK-HOTGVXAUSA-N Phe-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 FSXRLASFHBWESK-HOTGVXAUSA-N 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 102000003629 TRPC3 Human genes 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- AUEJLPRZGVVDNU-STQMWFEESA-N Tyr-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-STQMWFEESA-N 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000001420 bacteriolytic effect Effects 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 1
- 239000001177 diphosphate Substances 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229960005051 fluostigmine Drugs 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000005185 salting out Methods 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000019086 sulfide ion homeostasis Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 108010078580 tyrosylleucine Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
- C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
【発明の詳細な説明】 ・ − 6 一 「産業上の利用分野] 本発明は、耐熱性プロテアーゼ及びその製法に関する。[Detailed description of the invention] ・ − 6 1 “Industrial application field” The present invention relates to a thermostable protease and a method for producing the same.
さらに詳しくは、中等度好熱菌バチルス・ステアロサー
モフィルス(Bacillusstearotherm
ophNus )の培養液から抽出して得られる耐熱性
の高くかつ比活性の高い、耐熱性プロテアーゼ(以下、
プロテアーゼT OS 011−1と記す)及びその製
法に関する。For more information, see the moderate thermophile Bacillus stearothermophilus.
A thermostable protease (hereinafter referred to as
The present invention relates to protease TOS 011-1) and its production method.
[従来の技術]
従来、耐熱性プロテアーゼとしては、中等度好熱菌バチ
ルス・サーモプロテオリティカス(Bacillus
thermoproteolyticus)の生産す
るサーモライシンが一般的でまた工業的にも広く利用さ
れている。このサーモライシンは熱に対してのみならず
、有機溶媒、尿素などにも非常に安定である。そのため
研究用試薬としてのみでなく、各種食品加工用、洗剤添
加用など広い分野にわたってかつ力価を減することなく
長時間の使用に耐える。[Prior Art] Conventionally, as a thermostable protease, a moderate thermophilic bacterium Bacillus thermoproteolyticus has been used.
Thermolysin produced by P. thermoproteolyticus is common and widely used industrially. This thermolysin is extremely stable not only against heat but also against organic solvents, urea, and the like. Therefore, it can be used not only as a research reagent, but also in a wide range of fields such as various food processing and detergent additives, and can withstand long-term use without decreasing its potency.
[発明か解決しようとする問題点]
このようにサーモライシンは耐熱性を有するすぐれた蛋
白質分解酵素であるが、この酵素よりさらに耐熱性が高
く、かつ比活性の高い酵素が存在すれば、使用範囲はさ
らに広がりまた少量の使用でより高い酵素反応を示す。[Problem to be solved by the invention] As described above, thermolysin is an excellent proteolytic enzyme with heat resistance, but if an enzyme with higher heat resistance and specific activity exists than this enzyme, the range of use would be limited. is more widespread and also shows higher enzymatic response when used in small amounts.
本発明の目的はこのような酵素を提供することにある。It is an object of the present invention to provide such an enzyme.
[問題点を解決するための手段及び作用]木発明者らは
以上のような点に着目し、サーモライシンより耐熱性が
高くかつ比活性の高いプロテアーゼについて検討した結
果、サーモライシン類似の構造を有し、さらに耐熱性か
高くかつ比活性の上昇したプロテアーゼを見出し、本発
明に至った。[Means and actions for solving the problem] The inventors of the tree focused on the above points, and as a result of studying proteases with higher heat resistance and higher specific activity than thermolysin, they found that they have a structure similar to thermolysin. Furthermore, they discovered a protease with high heat resistance and increased specific activity, leading to the present invention.
本発明は、このようなプロテアーゼ及びその好適な製造
方法に関するものである。The present invention relates to such a protease and a suitable method for producing the same.
すなわち本発明は、下記の特徴を有するプロテアーゼで
ある。That is, the present invention is a protease having the following characteristics.
分 子 量: 34400 (ゲルろ適法、 5DS
−PAGE)34176 (アミノ酸組成)
pH安定性=37°C230分の処理後pH[i〜9の
範囲で90%以上の活性を有し安定で
ある。Molecular weight: 34400 (gel filtration method, 5DS
-PAGE) 34176 (Amino acid composition) pH stability = After treatment at 37°C for 230 minutes, the pH is stable with an activity of 90% or more in the range of i to 9.
至適p H: 6.5〜6.5 (H’C,2m1c
a2+存在下)
至適温度=75〜80℃(2m1ca2+存在下でカゼ
インを基質とし、20分間反応した
とき)
温度安定性=80℃、30分間の熱処理後の残存活性;
100%
90℃、30分間の熱処理後の残存活
性:約45%
(10InMTris−HCl、 2mMCaCl2
. pH7,0中)
含有金属:タンパク1分子当たり亜鉛1原子阻 害 剤
:エチレンジアミンテトラアセテート(EDTA) 、
1.10−0−フェナントロリン、ホスホラミドン
紫外線吸収スペクトル: 280nm付近基質特異性:
酸化インスリンβ鎖の分解において次の部分を分解する
。Optimum pH: 6.5-6.5 (H'C, 2m1c
(in the presence of a2+) Optimal temperature = 75-80°C (when reacting for 20 minutes using casein as a substrate in the presence of 2m1ca2+) Temperature stability = residual activity after heat treatment at 80°C for 30 minutes;
100% Residual activity after heat treatment at 90°C for 30 minutes: Approximately 45% (10InMTris-HCl, 2mMCaCl2
.. (at pH 7.0) Metal content: 1 atom of zinc per protein molecule Inhibitor: ethylenediaminetetraacetate (EDTA),
1.10-0-phenanthroline, phosphoramidone ultraviolet absorption spectrum: Substrate specificity around 280 nm:
In the decomposition of oxidized insulin β chain, the following parts are decomposed:
Nl2 ++1H25O3)!
↑ S O3H
−Leu−Va1−Glu−A1a−Leu−Tyr−
Leu−Val−Cys−G1y↑
↑ ↑ ↑−Glu−Arg−Gl
y−Phe−Phe−Tyr−Thr−Pro−Lys
−Ala↑ ↑ ↑ ↑ア
ミノ酸配列:
11eThrGIyThrSerThrValG1yV
alG1yArgG1yValLeuG 1 yAs
pGlnLysAs n l 1 eAs nTh r
Th rTy rSerTh rTy rTyrTyr
LeuGInAspAsnThrArgGIyAsnG
IyllePheThrTyrAs pA 1 aLy
sTy rA rgTh rTh rLeuProG
1ySerLeuT rpAlaAspAlaAspA
snGlnPhePheAlaSerTyrAspAl
aPro 。Nl2 ++1H25O3)! ↑ S O3H -Leu-Va1-Glu-A1a-Leu-Tyr-
Leu-Val-Cys-G1y↑
↑ ↑ ↑−Glu−Arg−Gl
y-Phe-Phe-Tyr-Thr-Pro-Lys
-Ala↑ ↑ ↑ ↑Amino acid sequence: 11eThrGIyThrSerThrValG1yV
alG1yArgG1yValLeuG 1 yAs
pGlnLysAs n l 1 eAs nTh r
Th rTy rSerTh rTy rTyrTyr
LeuGInAspAsnThrArgGIyAsnG
IyllePheThrTyrAs pA 1 aLy
sTyrA rgTh rTh rLeuProG
1ySerLeuT rpAlaAspAlaAspA
snGlnPhePheAlaSerTyrAspAl
aPro.
Al aV、al AspA l aHi 5TyrT
yrA 1 aG 1yVal ThrTyrAspT
yrTyrLysAsnValHisAsnArgLe
uSerTyrAspG1yAsnAsnA1aA1a
11eArgSerSerValH1sTyrSerG
InGIyTyrAsnAsnA1aPheTrpAs
nG1ySerC1nMetValTyrG1yAsp
GlyAspG1yG]nThrPhel 1ePro
LeuSerG1yG1ylleAspValVal
A 1at(1sG1uLeuTh rtli sA
1aValTh rAs pTyrThrA laG
1 yLeu l ]eTy rGlnAsnG 1u
SerG1 yA la I l eAsnG 1uA
Ia11eSerAspl1ePheG1yThrL
euValG1uPheTyrA1aAsnLysAs
nProAspTrpG1ul1eG1yG1uAsp
ValTyrThrProGlyl1eSerG1yA
spSerLeuArgSerMetSerAspPr
oAspLysTyrG1yAspProAspHis
TyrSerLysArgTyrThrGIyThrG
]nAspAsnGlyG1yValHislleAs
nSerGlyllelleAsnLysA 1aA
laTyrLeu I 1eSerG 1nGIyG1
yTh rHi sTyrGlyValSerVal
ValG1ylleG1yArgAspLysLeuG
1yLys11ePheTyrArgA1aLeuTh
rG1nTyrLeuThrProThr’SerAs
nPheSerG1nLeuArgA1aA1aA1a
ValG1nSerAIaThrAspLeuTyrG
1ySerThrSerG1nG1uValA1aSe
rValLysGInA]aPheAspA1aVal
G1yValLys塩基配列:
ATAACAGGAACATCAACTGTCGGAG
TGGGAAGAGGAGTACTTTATTGTCC
TTGTAGTTGACAGCCTCACCCTTCT
CCTCATGAAGGTGATCAAAAAAATA
TTAATACAACCTACTCTACGTACTA
CCCACTAGTTTTTTTATAATTATGT
TGGATGAGATGCATGATGTATTTAC
AAGATAATACGCGTGGAAATGGGAT
TTTCACGTATATAAATGTTCTATTA
TGCGCACCTTTACCCTAAAAGTGCA
TAGATGCGAAATACCGTACGACATT
GCCGGGAAGCTTATGGGCACTACGC
TTTATGGCATGCTGTAACGGCCCTT
CGAATACCCGTGATGCAGATAACCA
ATTTTTTGCGAGCTATGACGCTCCA
GCGCTACGTCTATTGGTTAAAAAAC
GCTCGATACTGCGAGGTCGCGTTGA
TGCTCATTATTACGCTGGTGTGACA
TATGACTACTATCAACTACGAGTAA
TAATGCGACCACACTGTATACTGAT
CATAAAAAATGTTCATAACCGTCTC
AGCTACGACGGAAATAATGCATTTT
TACAAGTATTGGCAGAGTCGATGCT
GCCTTTATTACGTGCTATTAGATCA
TCCGTTCATTATAGCCAAGGCTATA
ATAACCGATAATCTAGTAGGCAAGT
AATATCGGTTCCGATATTATTGGCA
TTTTGGAACGGTTCGCAAATGGTGT
ATGGCGATGGTGATCGTAAAACCTT
GCCAAGCGTTTACCACATACCGCTA
CCACTAGGTCAAACATTTATTCCAC
TTTCTGGTGGTATTGATGTGGTCCC
AGTTTGTAAATAAGGTGAAAGACCA
CCATAACTACACCAGGCTCATGAGT
TAACGCATGCCGTAACCGATTATAC
AGCCGGACGAGTACTCAATTGCGTA
CGGCATTGGCTAA’TATGTCGGCCT
CTCATTTATCAAAACGAATCTGGTG
CAATTAATGAGGCAATAGAGTAAAT
AGTTTTGCTTAGACCACGTTAATTA
CTCCGTTATTCTGATATTTTTGGAA
(JTTAGTCGAATTTTACGCTAACAA
AAGACTATAAAAACCTTGCAATCAG
CTTAAAATGCGATTGTTTAATCCAG
ATTGGGAAATTGGAGAGGATGTGTA
TACACCTGGTTTAGGTCTAACCCTT
TAACCTCTCCTACACATATGTGGAC
CAATTTCAGGGGATTCGCTCCGTTC
GATGTCCGATCCGGACAAGTAAAGT
CCCCTAAGCGAGGCAAGCTACAGGC
TAGGCCTGTTCTATGGTGATCACGA
TCCATATTCAAAGCGCTATACAGGC
ACGATACCACTAGTGCTAGGTATAA
GTTTCGCGATATGTCCGT(iCCAAG
ATAATGGCGGGGTTCATATCAATAG
CGGAATTATCAACGTTCTATTACCG
CCCCAAGTATAGTTATCGCCTTAAT
AGTTGAAAGCCGCTTATTTGATTAG
CCAAGGCGGTACGCATTACGGTTTT
CGGCGAATAAACTAATCGGTTCCGC
CATGCGTAATGCCAGTGAGTGTTGT
CGGAATCGGACGCGATAAATTGGGG
AAAATTCACTCACAACAGCCTTAGC
CTGCGCTATTTAACCCCTTTTAATT
CTATCGTGCATTAACGCAATATTTA
ACACCAACGTCCAACAAGATAGCAC
GTAATTGCGTTATAAATTGTGGTTG
CAGGTTGTTTAGCCAACTTCGTGCT
GCCGCTGTTCAATCAGCCACTGACA
AATCGGTTGAAGCACGACGGCGACA
AGTTAGTCGGTGACTGTTGTACGGT
TCGACAAGCCAGGAAGTCGCTTCTG
TGAAGCAGAACATGCCAAGCTGTTC
GGTCCTTCAGCGAAGACACTTCGTC
GCCTTTGATGCGGTAGGGGTGAAAC
GGAAACTACGCCATCCCCACTTTまた
本発明はプロテアーゼTOSOH−1の好適な製造方法
に関するものであり、バチルス・ステアロサーモフィル
ス(Bacillus
stearothermophilus )に属し、プ
ロテアーゼTOSOH−1を生産する細菌を培養し、培
養液からプロテアーゼTOSO■−1を採取することを
特徴とするプロテアーゼTOSOH−1の製法に関する
。Al aV, al AspAl aHi 5TyrT
yrA 1 aG 1yVal ThrTyrAspT
yrTyrLysAsnValHisAsnArgLe
uSerTyrAspG1yAsnAsnA1aA1a
11eArgSerSerValH1sTyrSerG
InGIyTyrAsnAsnA1aPheTrpAs
nG1ySerC1nMetValTyrG1yAsp
GlyAspG1yG]nThrPhe1ePro
LeuSerG1yG1ylleAspValVal
A 1at(1sG1uLeuTh rtli sA
1aValTh rAs pTyrThrA laG
1 yLeu l ]eTyrGlnAsnG 1u
SerG1 yA la I le AsnG 1uA
Ia11eSerAspl1ePheG1yThrL
euValG1uPheTyrA1aAsnLysAs
nProAspTrpG1ul1eG1yG1uAsp
ValTyrThrProGlylleSerG1yA
spSerLeuArgSerMetSerAspPr
oAspLysTyrG1yAspProAspHis
TyrSerLysArgTyrThrGIyThrG
]nAspAsnGlyG1yValHislleAs
nSerGlyllelleAsnLysA 1aA
laTyrLeu I 1eSerG 1nGIyG1
yTh rHi sTyrGlyValSerVal
ValG1ylleG1yArgAspLysLeuG
1yLys11ePheTyrArgA1aLeuTh
rG1nTyrLeuThrProThr'SerAs
nPheSerG1nLeuArgA1aA1aA1a
ValG1nSerAIaThrAspLeuTyrG
1ySerThrSerG1nG1uValA1aSe
rValLysGInA]aPheAspA1aVal
G1yValLys base sequence: ATAACAGGAACATCAACTGTCGGAG
TGGGAAGAGGAGTACTTTATTGTCC
TTGTAGTTGACAGCCTCACCCTTCT
CCTCATGAAGGTGATCAAAAAAATA
TTAATAACAACCTACTCTACGTACTA
CCCACTAGTTTTTTTTATAATTATGT
TGGATGAGATGCATGATGTATTTAC
AAGATAATACGCGTGGAAATGGGAT
TTTCACGTATATAAATGTTCTATTA
TGCGCACCTTTTACCCTAAAAGTGCA
TAGATGCGAAATACCGTACGACATT
GCCGGGAAGCTTATGGGGCACTACGC
TTTATGGCATGCTGTAACGGCCCT
CGAATAACCCGTGATGCAGATAACCA
ATTTTTTGCGAGCTATGACGCTCCA
GCGCTACGTCTATTGGTTAAAAAAAC
GCTCGATACTGCGAGGTCGCGTTGA
TGCTCATTATTACGCTGGTGTGACA
TATGACTACTATCAACTACGAGTAA
TAATGCGACCACACTGTATACTGAT
CATAAAAAATGTTCATAACCGTCTC
AGCTACGACGGAAAATAATGCATTTT
TACAAGTATTGGCAGAGTCGATGCT
GCCTTTATTACGTGCTATTAGATCA
TCCGTTCATTATAGCCAAGGCTATA
ATAACCGATAATCTAGTAGGCAAGT
AATATCGGTTCCGATAATTATTGGCA
TTTTGGAACGGTTCGCAAATGGTGT
ATGGCGATGGTGATCGTAAAACCTT
GCCAAGCGTTTACCACATACCGCTA
CCACTAGGTCAACATTTATTCCAC
TTTCTGGTGGTATTGATGTGGTCC
AGTTTGTAAAATAAGGTGAAAGACCA
CCATAACTACACCAGGCTCATGAGT
TAACGCATGCCGTAACCGATTATAC
AGCCGGACGAGTACTCAATTGCGTA
CGGCATTGGCTAA'TATGTCGGCCT
CTCATTTATCAAAACGAATCTGGTG
CAATTAAATGAGGCAATAGAGTAAAT
AGTTTTGCTTAGACCACGTTAATTA
CTCCGTTATTCTGATATTTTGGAA
(JTTAGTCGAATTTTACGCTAACAA
AAGACTATAAAAACCTTGCAATCAG
CTTAAAATGCGATTGTTTAATCCAG
ATTGGAAAATTGGAGAGGATGTGTA
TACACCTGGTTTTAGGTCTAACCCTT
TAACCTCTCCTACACATATGTGGAC
CAATTTCAGGGGATTCGCTCCGTTC
GATGTCCGATCCGGACAAGTAAAGT
CCCCTAAGCGAGGCAAGCTACAGGC
TAGGCCTGTTCTATGGTGATCACGA
TCCATATTCAAAGCGCTATACAGGC
ACGATACCACTAGTGCTAGGTATAA
GTTTCGCGATATGTCCGGT(iCCAAG
ATAATGGCGGGGTTCATATCAATAG
CGGAATTATCAACGTTCTATTACCG
CCCCAAGTATAGTTATCGCCTTAAT
AGTTGAAAGCCGCTTTATTGATTAG
CCAAGGCGGTACGCATTACGGTTTT
CGGCGAATAAAAACTAATCGGTTCCGC
CATGCGTAATGCCAGTGAGTGTTGT
CGGAATCGGACGCGATAAATTGGGG
AAAATTCACTCACAACAGCCTTAGC
CTGCGCTATTTAACCCCCTTTTAATT
CTATCGTGCATTAACGCAATATTTA
ACACCAACGTCCAACAAGATAGCAC
GTAATTGCGTTAAAAATTGTGGTTG
CAGGTTGTTTTAGCCAAACTTCGTGCT
GCCGCTGTTCAATCAGCCACTGACA
AATCGGTTGAAGCACGACGGCGACA
AGTTAGTCGGTGACTGTTGTACGGT
TCGACAAGCCAGGAAGTCGCTTCTG
TGAAGCAGAACATGCCAAGCTGTTC
GGTCCTTCAGCGAAGACACTTCGTC
GCCTTTGATGCGGTAGGGGTGAAAC
GGAAAACTACGCCATCCCCACTTTThe present invention also relates to a preferred method for producing protease TOSOH-1, in which a bacterium belonging to Bacillus stearothermophilus that produces protease TOSOH-1 is cultured, and protease TOSOH is extracted from the culture solution. O■ The present invention relates to a method for producing protease TOSOH-1, which comprises collecting protease TOSOH-1.
本発明で使用されるプロテアーゼTOSOH−1生産微
生物は、プロテアーゼTOSOII−1を生産すること
ができるバチルス・ステアロサーモフィルス(Baci
llus stearothermophilus
)に属する全ての菌株であり、突然変異株、および変種
をも包含する。中でもとくに好ましい菌株は、本発明者
らが土壌の中から分離したプロテアーゼTOSOH−1
の生産性が著しく高い菌株バチルス・ステアロサーモフ
ィルスMK−232 (Bacillusstearo
thermophilus MK−232) (微工
研菌寄第9645号)である。The protease TOSOH-1 producing microorganism used in the present invention is Bacillus stearothermophilus (Bacillus stearothermophilus) which can produce protease TOSOII-1.
llus stearothermophilus
), including mutant strains and variants. Among these, a particularly preferred strain is protease TOSOH-1, which the present inventors isolated from soil.
Bacillus stearothermophilus MK-232, a strain with extremely high productivity.
thermophilus MK-232) (Feikoken Bibori No. 9645).
以下に本菌株の菌学的性質を示す。The mycological properties of this strain are shown below.
形態
細胞の形 桿菌
細胞の大きさ 1.OX 1.2μ×3.0〜5.
0μ多形性 なし
運動性 あり
胞子 形成する
胞子の形 円形
胞子の大きさ 0.6〜1.0μ×1.2μ抗酸性
なし
ダラム染色 十
成育状態
■肉汁寒天平板培養
成育の良否 良好
コロニーの形 円形
コロニーの表面形状 平滑、重輪
コロニーの隆起状態 偏平
コロニーの周縁 金縁
コロニーの内容 均一
コロニーの色調 クリーム色
コロニーの透明度 不透明
■肉汁寒天斜面培養
成育の良否 良好
−15=
コロニーの形 糸状
コロニーの表面形状 平滑
コロニーの透明度 不透明
コロニーの色調 クリーム色
■肉汁液体培養
表面の成育 なし
濁度 やや濁る
沈澱 粘調
■肉汁ゼラチン穿刺培養
ゼラチン液化 あり、50℃、5日■リドマスミ
ルク 液化凝固せず
生理的性質
硝酸塩の還元 陰性
脱窒反応 陰性
MRテスト 陽性
UPテスト 陰性
インドールの生成 陰性
硫化水素の生成 陽性
デンプンの加水分解 陽性
クエン酸の利用 陰性
色素の生成 なし
ウレアーゼ 陰性
オキシダーゼ 陰性
カタラーゼ 陽性
成育の範囲 至適pH7,0付近、50℃付近
が最適
酸素に対する態度 陰性
糖類から酸及びガスの生成の有無
アラビノース、キシロース、マンノース、フラクトース
、ガラクトースから酸を生成するがガスは生成しない。Morphology Cell shape Bacillus cell size 1. OX 1.2μ×3.0~5.
0μ Polymorphism None Motility Yes Spore Form of spore formed Circular spore size 0.6-1.0μ x 1.2μ Acid-fast
None Durham staining 10 Growth status ■ Quality of growth on broth agar plate Good colony shape Surface shape of circular colonies Smooth, raised condition of heavy-ringed colonies Periphery of flat colonies Contents of gold-rimmed colonies Color tone of uniform colonies Transparency of cream-colored colonies Opaque ■ Quality of growth on gravy agar slant culture Good - 15 = Colony shape Surface shape of filamentous colonies Transparency of smooth colonies Color tone of opaque colonies Cream color ■ Growth on gravy liquid culture surface None Turbidity Slightly cloudy sediment Viscosity ■ Meat juice gelatin Puncture culture gelatin Liquefaction Yes, 50℃, 5 days ■ Lidomus milk Physiological properties without liquefaction coagulation Reduction of nitrate Negative denitrification reaction Negative MR test Positive UP test Negative Indole generation Negative Hydrogen sulfide generation Positive Starch hydrolysis Positive citric acid utilization Negative Pigment production None Urease Negative oxidase Negative catalase Range of positive growth Optimum pH around 7.0, optimal attitude towards oxygen around 50℃ Negative Whether or not acid and gas are generated from sugars Acid from arabinose, xylose, mannose, fructose, galactose It does, but it does not produce gas.
麦芽糖、ショ糖、トレハロース、ソルビット、マンニッ
ト、イノジット、グリセリン、デンプンから酸もガスも
生成しない
7%塩化ナトリウム添加培地での成育
成育しない
フェニルアラニンデアミナーゼチロシンの分解陰性
カゼインの分解 陽性
0.02%アジ化ナトリウム添加培地での成育成育しな
い
従って本菌株は、バーシーズ・マニュアル・オブ・デタ
ミネイティブ・バクテリオロジー(Bergey’s
Manual of determinativeba
cteriology ) 8版によるバチルス・ステ
アロサーモフィルス(Bacillus
stearothermophilus )に属する菌
株と同定され、バチルス・ステアロサーモフィルス(B
acillusstearothermophilus
) MK−232と命名した。Maltose, sucrose, trehalose, sorbitol, mannitol, inosit, glycerin, starch Does not produce acid or gas Growth on medium supplemented with 7% sodium chloride No growth Phenylalanine deaminase Tyrosine degradation Negative Casein degradation Positive 0.02% This strain does not grow in sodium azide-supplemented media. Therefore, this strain is not recommended for growth in Bergey's Manual of Determinative Bacteriology.
Manual of determinativeba
cteriology) 8th edition, it was identified as a strain belonging to Bacillus stearothermophilus (Bacillus stearothermophilus).
acillus stearothermophilus
) It was named MK-232.
本発明のプロテアーゼTO8OH−1を製造するには、
上記のバチルス中ステアロサーモフィルス(Bacil
lus stearothermophllus )
に属する菌株を培養し、該培養液よりプロテアーゼTO
3OH−1を採取すればよい。例えば、バチルス・ステ
アロサーモフィルス(Bacillus
stearothermophilus ) MK−2
32を炭素源、窒素源、塩類、その他の物質を含有する
培地に接種し、適当な温度、例えば約50〜60℃で酵
素力価が最高に達するまでの適当な時間、振とうまたは
通気攪拌培養して生産する方法がある。To produce the protease TO8OH-1 of the present invention,
Among the Bacillus mentioned above, Stearothermophilus (Bacillus)
lus stearothermophllus )
Protease TO
3OH-1 may be collected. For example, Bacillus stearothermophilus MK-2
32 is inoculated into a medium containing a carbon source, nitrogen source, salts, and other substances, and shaken or agitated with aeration at an appropriate temperature, for example, about 50 to 60°C, for an appropriate time until the enzyme titer reaches its maximum. There is a method of culturing and producing it.
」二記のようにして培養された培養液は、遠心分離、濾
過などの方法で清澄にした後、この清澄液に例えば硫酸
アンモニウムを加えて目的の酵素を沈澱させ、採取する
ことができる。またさらに、イオン交換樹脂、ゲル濾過
法を利用して、上記沈澱物を精製して極めて活性が高い
プロテアーゼTO3OH−1を得ることができる。The culture solution cultured as described in Section 2 above can be clarified by centrifugation, filtration, or the like, and then, for example, ammonium sulfate may be added to the clarified solution to precipitate the enzyme of interest, and the enzyme can be collected. Furthermore, the above precipitate can be purified using an ion exchange resin and a gel filtration method to obtain extremely highly active protease TO3OH-1.
このようにして得られた新規のプロテアーゼTO8Oi
(−1の理化学的性質を以下に示す。The novel protease TO8Oi thus obtained
(The physical and chemical properties of -1 are shown below.
(1)作用
カゼインを基質として使用した蛋白質分解作用の好適p
Hは図1に示すごとく6〜8であり、至適1)H8,5
〜7.0の中性プロテアーゼである。またプロテアーゼ
TO8OH−1とサーモライシンをTSKgelG−2
000SWカラム(商品名、東ソー■製)を用いゲル濾
過により5DS−PAGE、 HPLC分析により完全
にシングルバンドになるまで精製を行い、両者のカゼイ
ンを基質とした場合の比活性を表1に示す。(1) Preferred p for proteolytic action using casein as a substrate
H is 6 to 8 as shown in Figure 1, and optimal 1) H8,5
~7.0 neutral protease. In addition, protease TO8OH-1 and thermolysin were added to TSKgelG-2.
Purification was performed by gel filtration using a 000SW column (trade name, manufactured by Tosoh ■) until a completely single band was obtained by 5DS-PAGE and HPLC analysis, and the specific activities of both cases when casein was used as a substrate are shown in Table 1.
サーモライシンに比ベプロテアーゼTO8OH−1は比
活性は約40%高いことがわかる。It can be seen that the specific activity of protease TO8OH-1 is about 40% higher than that of thermolysin.
表1 各酵素の比活性
(2)基質特異性
プロテアーゼTO8OH−1の特徴「基質特異性」の欄
に示したように、酸化インスリンβ鎖を基質として分解
を行わせたところ、His−Leu 、 Ala−Le
u 。Table 1 Specific activity of each enzyme (2) Substrate specificity Characteristics of protease TO8OH-1 As shown in the "Substrate specificity" column, when decomposition was carried out using oxidized insulin β chain as a substrate, His-Leu, Ala-Le
u.
Tyr−Leu 、 Leu−Val 、 Gly−P
he 、 Phe−Phe 、 Phe−Tyr 、
Lys−Alaといった疎水性アミノ酸が存在する部分
を分解する。Tyr-Leu, Leu-Val, Gly-P
he, Phe-Phe, Phe-Tyr,
Decomposes the portion where hydrophobic amino acids such as Lys-Ala are present.
(3)至適1)H
カゼインを基質として使用した蛋白質分解作用における
I)Hの影響を図1に示す。至適pHは6.5〜6.5
である。(3) Optimal 1)H The influence of I)H on proteolysis using casein as a substrate is shown in Figure 1. Optimum pH is 6.5-6.5
It is.
(4) pl+安定性
各種pH(pH5〜8ニリン酸緩衝液、pH6〜11ニ
ゲリシン−NaOH緩衝液)で37℃、60分間処理後
の残存活性を測定した結果を図4に示す。pH6〜9の
範囲でほぼ100%の残存活性を示した。(4) pl+stability The residual activity after treatment at various pH values (pH 5-8 diphosphate buffer, pH 6-11 nigericin-NaOH buffer) at 37° C. for 60 minutes is shown in FIG. 4. Almost 100% residual activity was shown in the pH range of 6 to 9.
(5)力価の測定法
1 mlの2%カゼイン溶液(50111M トリス−
塩酸。(5) Method for measuring titer 1 ml of 2% casein solution (50111M Tris-
hydrochloric acid.
5 mMcac12. pH7,5)に1 mlの各試
料を加え、−定時間後に反応停止液(0,33M酢酸、
0.22M酢酸ナトリウム、0.1M )リクロロ酢酸
)を2 ml加え、室温で30分間放置した。これをワ
ットマンNO,l濾紙で濾過した。これとは別にカゼイ
ン溶液に反応停止液を入れ、試料を加え、濾過したもの
を基準としてA nmを測定し、チロシン溶液を基
準としたA の検量線を作成してプロテアーゼ活性を
測定した。1単位は37℃で1分間に1μgのチロシン
相当物質をトリクロロ酢酸可溶性区分に遊離させる酵素
量とした。5mMcac12. 1 ml of each sample was added to the solution (pH 7.5), and after a certain period of time, the reaction stop solution (0.33M acetic acid,
2 ml of 0.22M sodium acetate, 0.1M dichloroacetic acid) was added, and the mixture was allowed to stand at room temperature for 30 minutes. This was filtered through Whatman NO.1 filter paper. Separately, a reaction stop solution was added to the casein solution, a sample was added, and A nm was measured using the filtered sample as a reference. A calibration curve of A was prepared using the tyrosine solution as a reference to measure protease activity. One unit was defined as the amount of enzyme that liberated 1 μg of a substance equivalent to tyrosine into the trichloroacetic acid soluble fraction in 1 minute at 37°C.
(6)至適温度
カゼインを基質として使用した蛋白質分解作用の温度依
存性を図2に示す。本酵素の作用最適温度は約75℃に
ある。(6) Optimal temperature The temperature dependence of proteolytic action using casein as a substrate is shown in Figure 2. The optimum temperature for the action of this enzyme is approximately 75°C.
(7)温度安定性
−21=
温度安定性を図3に示す。プロテアーゼT OS OH
−1は80℃、30分熱処理後の残存活性は100%と
非常に安定で、90℃、30分熱処理後の残存活性にお
いてもサーモライシンが約35%であるのに対し、プロ
テアーゼTO8OH−1は約45%と約10%熱安定性
が上昇し、非常に熱安定性の高い酵素である。(7) Temperature stability -21= Temperature stability is shown in FIG. Protease T OS OH
-1 has a very stable residual activity of 100% after heat treatment at 80℃ for 30 minutes.While thermolysin has a residual activity of about 35% after heat treatment at 90℃ for 30 minutes, protease TO8OH-1 has The thermostability increases by about 45% and about 10%, making it an extremely thermostable enzyme.
(8) pHによる失活の条件
図4に示すごと<、pH5付近で失活が始まり、pH5
,0、37℃、60分間で約30%が失活した。一方ア
ルカリ側では、pH10付近で失活が始まり、pH11
,37°0160分間で約40%が失活した。(pH5
〜8ニリン酸緩衝液、pug〜11ニゲリシン−N a
OH緩衝液)(9)阻害剤の影響
阻害剤の影響を表2に示す。さらに金属塩による影響を
表3に示す。(8) Conditions for inactivation due to pH As shown in Figure 4, inactivation begins at around pH 5;
Approximately 30% of the activity was inactivated at 0.37°C for 60 minutes. On the other hand, on the alkaline side, deactivation begins around pH 10, and pH 11
, about 40% was deactivated in 37°0160 minutes. (pH 5
~8 Niphosphate buffer, pug~11 Nigericin-Na
OH buffer) (9) Influence of inhibitors The influence of inhibitors is shown in Table 2. Furthermore, Table 3 shows the influence of metal salts.
表2
EDTA :エチレンジアミンテトラアセテイツクアシ
ッド
DFP ニジイソプロピルフルオロホスフェートPMS
P :フェニルメチルスルホニルフルオライド
表3
(lO)分子量
ゲル濾過法、5DS−ポリアクリルアミドゲル電気泳動
法により測定した分子量は約34400.アミノ酸配列
からの分子量は34176である。Table 2 EDTA: Ethylenediaminetetraacetate acid DFP diisopropylfluorophosphate PMS
P: Phenylmethylsulfonyl fluoride Table 3 (lO) Molecular weight The molecular weight measured by gel filtration method and 5DS-polyacrylamide gel electrophoresis method is approximately 34,400. The molecular weight from the amino acid sequence is 34,176.
(11)紫外線吸収スペクトル
図5に示すごとく、水溶液の吸収極大は約280nm付
近にあり、吸収極小は約245〜255nmにある。(11) Ultraviolet absorption spectrum As shown in Figure 5, the absorption maximum of the aqueous solution is around 280 nm, and the absorption minimum is around 245 to 255 nm.
(12)アミノ酸組成
プロテアーゼTO9OH−1の特徴「アミノ酸配列」の
欄に示すごとく、N末端アミノ酸からl1e−Thr−
Gly−Thr−8er−Thr−−−・のアミノ酸配
列をとり、37番目: Asn 、 119番目:
Ginのアミノ酸がサーモライシンのアミノ酸配列(3
7番目: Asp 、 119番目:Glu )と異
なる。アミノ酸組成は次のようであり、全部で316個
のアミノ酸から成る。(12) Amino acid composition Characteristics of protease TO9OH-1 As shown in the "Amino acid sequence" column, from the N-terminal amino acid to l1e-Thr-
Taking the amino acid sequence of Gly-Thr-8er-Thr---., position 37: Asn, position 119:
The amino acids of Gin are the amino acid sequence of thermolysin (3
7th: Asp, 119th: Glu). The amino acid composition is as follows, consisting of 316 amino acids in total.
Aha 2g、 Arg 10. Asn 20. A
sp 24. Cys O。Aha 2g, Arg 10. Asn 20. A
sp24. Cys O.
Gin 14. Glu 7 、 Gly 3B、 H
is 8 、 lle 18゜Leu l[i、 Ly
s 11. Met 2 、 Phe 10. Pro
8 。Gin 14. Glu 7, Gly 3B, H
is 8, lle 18゜Leu l[i, Ly
s 11. Met2, Phe10. Pro
8.
Ser 2B、 Thr 25. Trp 3 、 T
yr、26. Val 22(13)塩基配列
プロテアーゼTO8OH−1の特徴「塩基配列」の欄に
示すごとく、プロテアーゼTO8OH−1構造遺伝子は
948塩基対からなる。Ser 2B, Thr 25. Trp3, T
yr, 26. Val 22 (13) Base Sequence Characteristics of Protease TO8OH-1 As shown in the "base sequence" column, the structural gene of protease TO8OH-1 consists of 948 base pairs.
(14)比活性
カゼインを基質とした場合の比活性を表1に示す。本発
明の酵素は市販されているサーモライシンよりも約40
%も比活性の高い酵素である。(14) Specific activity Table 1 shows the specific activity when casein was used as a substrate. The enzyme of the present invention is approximately 40% more active than commercially available thermolysin.
% is also an enzyme with high specific activity.
(15)耐熱性 90℃、30分までの耐熱性試験の結果を図3に示す。(15) Heat resistance The results of the heat resistance test at 90° C. for up to 30 minutes are shown in FIG.
本発明の酵素は市販されているサーモライシンよりも約
10%も耐熱性の上昇した酵素である。The enzyme of the present invention is an enzyme with approximately 10% higher heat resistance than commercially available thermolysin.
[発明の効果コ
プロテアーゼToSOH−1は耐熱性が高く、かつ比活
性が高いため、使用範囲の広いプロテアーゼである。ま
たプロテアーゼTO8OH−1は本発明方法によって製
造することができる。[Effects of the Invention Coprotease ToSOH-1 has high heat resistance and high specific activity, so it is a protease that can be used in a wide range of applications. Furthermore, protease TO8OH-1 can be produced by the method of the present invention.
[実施例コ
次に実施例を示すが、本発明はこれら実施例のみに限定
されるものではない。[Examples] Next, examples will be shown, but the present invention is not limited to these examples.
実施例1
表4
表4に示す組成の培地500 mlを21容の坂ロフラ
スコに入れ120℃、15分滅菌する。同組成の培地で
培養したバチルス壷ステアロサーモフィルスMK−23
2の前培養液50m1を加え、37℃、150rpm、
24時間振とう培養した。培養液中のプロテアーゼは
約5000単位/ mlであった。培養後、硫酸アンモ
ニウムを70%飽和になるように加え、酵素活性画分を
析出させたのち、遠心分離(10000rpIIl、
10分)して集めた。集めた酵素をできるだけ少量の1
0mMトリス−塩酸、5mMのCaCl2 (poy
、o )に懸濁し、透析用セロハンチューブにつめ、両
端をむすんたのち24時間、15℃以下、同緩衝液中で
透析した。Example 1 Table 4 500 ml of a medium having the composition shown in Table 4 was placed in a 21 volume Sakaro flask and sterilized at 120°C for 15 minutes. Bacillus stearothermophilus MK-23 cultured in a medium with the same composition
Add 50 ml of preculture solution from step 2, and incubate at 37°C, 150 rpm,
Culture was carried out with shaking for 24 hours. The protease in the culture solution was approximately 5000 units/ml. After culturing, ammonium sulfate was added to 70% saturation to precipitate the enzyme active fraction, followed by centrifugation (10,000 rpm,
10 minutes) and collected. Transfer the collected enzymes to as small a quantity as possible.
0mM Tris-HCl, 5mM CaCl2 (poy
, o), packed in a cellophane tube for dialysis, tied both ends, and dialyzed in the same buffer at 15° C. or lower for 24 hours.
透析後、不溶物を遠心分離して除き、凍結乾燥し、得ら
れた粉末を粗酵素サンプルとした。粗酵素サンプルは次
の方法で分離精製した。すなわち粗酵素サンプル1gを
10m1の10111Mトリス−塩酸、5IIIMCa
C1□ (pH7,0)に溶解し、同緩衝液で平衡化し
たToyopearl−l(W2O(商品名、東ソー■
製)を充填したカラム(1,5X80cm)上部に静か
に流しこみ、同緩衝液で溶出する。ここで得た活性画分
をさらにTSKgel−G2000SW (商品名、東
ソー■製)にかけ、ピークフラクションを分取する。活
性画分は硫酸アンモニウム塩析(70%飽和)で集め、
透析したのち、凍結乾燥する。以上の方法に従って精製
し、11の培養液から0.1gのプロテアーゼTO8O
H−1を得た。After dialysis, insoluble matter was removed by centrifugation and freeze-dried, and the resulting powder was used as a crude enzyme sample. The crude enzyme sample was separated and purified using the following method. That is, 1 g of crude enzyme sample was mixed with 10 ml of 10111M Tris-HCl, 5IIIMCa.
Toyopearl-l (W2O (trade name, Tosoh ■) dissolved in C1□ (pH 7,0) and equilibrated with the same buffer
Pour the solution gently onto the top of a column (1.5 x 80 cm) packed with 100% of the same buffer solution and elute with the same buffer. The active fraction obtained here is further applied to TSKgel-G2000SW (trade name, manufactured by Tosoh ■), and a peak fraction is collected. The active fraction was collected by ammonium sulfate salting out (70% saturation).
After dialysis, it is freeze-dried. Purified according to the above method, 0.1 g of protease TO8O was obtained from the culture solution of 11.
H-1 was obtained.
実施例2
実施例1に従い精製したプロテアーゼTO8OI!−1
を用い、高濃度のNaC1中でのプロテアーゼ活性をみ
た。10111Mトリス−塩酸、5mMのCaC12(
pH7,0)中でNaC1濃度を0.5M 、 LM、
2M、 3M、 5M、と上昇させ、残存活性を測定
した。結果を図6に示す。Example 2 Protease TO8OI purified according to Example 1! -1
The protease activity was examined in high concentration NaCl. 10111M Tris-HCl, 5mM CaC12 (
pH 7,0) with NaCl concentration of 0.5M, LM,
The concentration was increased to 2M, 3M, and 5M, and the residual activity was measured. The results are shown in FIG.
図からも明らかなように、0.5Mでは無添加に比べ活
性が上昇し、また3M付近でも残存活性50%と、プロ
テアーゼTO8OH−1は他のプロテアーゼと比べ非常
に耐塩性のプロテアーゼである。As is clear from the figure, the activity increases at 0.5M compared to when no addition is made, and the remaining activity is 50% even at around 3M, making protease TO8OH-1 a very salt-tolerant protease compared to other proteases.
実施例3
実施例1に従い、精製したプロテアーゼTO8OH−1
を用い各種微生物を用い、本酵素の溶菌活性を測定した
。各培養菌体をアセトンを用いて乾燥させ、粉末とした
ものを基質とし、本酵素、リゾチーム、アクロモペプチ
ダーゼを酵素として用い、1分間に0.001濁度の減
少を1単位と定義し、各微生物に対する各酵素の溶菌活
性を比較した。Example 3 Protease TO8OH-1 purified according to Example 1
The bacteriolytic activity of this enzyme was measured using various microorganisms. Each cultured bacterial cell was dried using acetone and powdered as a substrate, and the present enzyme, lysozyme, and achromopeptidase were used as enzymes, and a decrease in turbidity of 0.001 per minute was defined as 1 unit, The lytic activity of each enzyme against each microorganism was compared.
表5
基質 スタフィロコッカス・アウレウスIP03761
基質 サツカロマイセス・セレビシェHUT 7119
このように既存の溶菌酵素、リゾチーム、アクロモペプ
チダーゼと比較しても同等もしくはそれ以上の溶菌活性
を示した。Table 5 Substrate Staphylococcus aureus IP03761
Substrate Satucharomyces cerevisiae HUT 7119
In this way, compared to the existing lytic enzymes, lysozyme, and achromopeptidase, it showed the same or higher lytic activity.
図1はプロテアーゼTO8OH−1の至適pHを示す図
である。
図2はプロテアーゼTO8OH−1の至適温度を示す図
である。
図3はプロテアーゼTO3OH−1と市販酵素サーモラ
イシンとの温度安定性、耐熱性を比較したものを示す図
である。
図4はプロテアーゼTO3OH−1のI)H安定性を示
す図である。
図5はプロテアーゼTO8OH−1の水溶液の紫外線吸
収スペクトルを示す図である。
図6はプロテアーゼTO8OH−1の塩に対する耐性度
を示す図である。FIG. 1 is a diagram showing the optimum pH of protease TO8OH-1. FIG. 2 is a diagram showing the optimum temperature of protease TO8OH-1. FIG. 3 is a diagram showing a comparison of the temperature stability and heat resistance of protease TO3OH-1 and the commercially available enzyme thermolysin. FIG. 4 is a diagram showing the I)H stability of protease TO3OH-1. FIG. 5 is a diagram showing the ultraviolet absorption spectrum of an aqueous solution of protease TO8OH-1. FIG. 6 is a diagram showing the degree of resistance of protease TO8OH-1 to salt.
Claims (3)
。 分子量:34400(ゲルろ過法、SDS−PAGE)
34176(アミノ酸組成) pH安定性:37℃、30分の処理後pH6〜9の範囲
で90%以上の活性を有し安定である。 至適pH:6.5〜8.5(60℃、2mMCa^2^
+存在下) 至適温度:75〜80℃(2mMCa^2^+存在下で
カゼインを基質とし、20分間反応したとき) 温度安定性:80℃、30分間の熱処理後の残存活性:
100% 90℃、30分間の熱処理後の残存活性:約45% (10mMTris−HCl、2mMCaCl_2、p
H7.0中) 含有金属:タンパク1分子当たり亜鉛1原子阻害剤:エ
チレンジアミンテトラアセテート(EDTA)、1,1
0−O−フェナントロリン、ホスホラミドン紫外線吸収
スペクトル:280nm付近基質特異性:酸化インスリ
ンβ鎖の分解において次の部分を分解する。▲数式、化
学式、表等があります▼ アミノ酸配列: 【遺伝子配列があります】 塩基配列: 【遺伝子配列があります】(1) A thermostable protease having the following enzymatic chemical properties. Molecular weight: 34400 (gel filtration method, SDS-PAGE)
34176 (Amino acid composition) pH stability: Stable with 90% or more activity in the pH range of 6 to 9 after treatment at 37°C for 30 minutes. Optimum pH: 6.5-8.5 (60℃, 2mMCa^2^
+) Optimal temperature: 75-80°C (when reacted for 20 minutes using casein as a substrate in the presence of 2mMCa^2^+) Temperature stability: Residual activity after heat treatment at 80°C for 30 minutes:
100% Residual activity after heat treatment at 90°C for 30 minutes: Approximately 45% (10mM Tris-HCl, 2mMCaCl_2, p
H7.0) Metal content: 1 atom of zinc per protein molecule Inhibitor: Ethylenediaminetetraacetate (EDTA), 1,1
0-O-Phenanthroline, Phosphoramidone Ultraviolet absorption spectrum: Around 280 nm Substrate specificity: Decomposes the following parts in the decomposition of oxidized insulin β chain. ▲There are mathematical formulas, chemical formulas, tables, etc.▼ Amino acid sequence: [There is a gene sequence] Base sequence: [There is a gene sequence]
llus¥stearothermophilus¥)
に属する菌株を培養して、該培養液より特許請求の範囲
第1項記載の耐熱性プロテアーゼを採取することを特徴
とする耐熱性プロテアーゼの製法。(2) Bacillus stearothermophilus (¥Baci
llus\stearothermophilus\)
1. A method for producing a heat-stable protease, which comprises culturing a strain belonging to the following: and collecting the heat-stable protease according to claim 1 from the culture solution.
232(¥Bacillus¥¥stearother
mophilus¥MK−232)である特許請求の範
囲第2項記載の方法。(3) The strain is Bacillus stearothermophilus MK-
232(¥Bacillus¥¥stearother
mophilus\MK-232).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25374987A JPH0195778A (en) | 1987-10-09 | 1987-10-09 | Heat-resistant protease and its production |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25374987A JPH0195778A (en) | 1987-10-09 | 1987-10-09 | Heat-resistant protease and its production |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0195778A true JPH0195778A (en) | 1989-04-13 |
Family
ID=17255606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP25374987A Pending JPH0195778A (en) | 1987-10-09 | 1987-10-09 | Heat-resistant protease and its production |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0195778A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111568855A (en) * | 2020-06-08 | 2020-08-25 | 山东大学 | Preparation method of injectable hydrogel and application of injectable hydrogel in postoperative tumor treatment |
-
1987
- 1987-10-09 JP JP25374987A patent/JPH0195778A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN111568855A (en) * | 2020-06-08 | 2020-08-25 | 山东大学 | Preparation method of injectable hydrogel and application of injectable hydrogel in postoperative tumor treatment |
CN111568855B (en) * | 2020-06-08 | 2022-02-08 | 山东大学 | Preparation method of injectable hydrogel and application of injectable hydrogel in postoperative tumor treatment |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04271785A (en) | Enzymic solid pharmaceutical and its production | |
JPH05219942A (en) | Variant of clostridium and histolyticum method for production thereof and usage thereof | |
JP2882652B2 (en) | Alkaline protease and its producing microorganism | |
JPH0195778A (en) | Heat-resistant protease and its production | |
JPH02234678A (en) | Amino acid amide hydrolase and use thereof | |
JP2676453B2 (en) | Alkaline isoamylase, microorganism producing the same, and method for producing the alkaline isoamylase | |
JP3820617B2 (en) | ε-Poly-L-lysine-degrading enzyme and method for producing ε-poly-L-lysine with low polymerization degree using the same | |
JP3603396B2 (en) | ε-Poly-L-lysine degrading enzyme and process for producing ε-poly-L-lysine using the same | |
JP3055041B2 (en) | α-1,2-mannosidase, method for producing the same, and bacteria producing the same | |
KR950009838B1 (en) | Protease from streptomyces thermonitrificans | |
JP2509540B2 (en) | Novel microorganism that produces new protease | |
JP2873936B2 (en) | Cold-active protease and its production | |
JP2985018B2 (en) | New microorganism | |
JPH04211369A (en) | Halophilic alkali amylase and production thereof | |
JP3026111B2 (en) | Novel alkaline protease and method for producing the same | |
CA1219827A (en) | Thermo-stable micro-organism | |
JPS6248380A (en) | Production of cephalosporin c acylase | |
JPH05268954A (en) | New alkaline protease and its production | |
JPH05176765A (en) | New gamma-gtp and its production | |
JPH07106148B2 (en) | Novel enzyme having agarase activity, method for producing the same, and novel microorganism producing the enzyme | |
JPS63192387A (en) | Thermostable protease and production thereof | |
JPS6248379A (en) | Production of cephalosporin c acylase | |
JPH0616704B2 (en) | Bacterial catalase resistant to fluoride ions and Micrococcus sp. KWI-5 strain | |
JPH0763368B2 (en) | Heat-resistant alkaline protease and method for producing the same | |
JPS58152482A (en) | Heat-resistant proteolytic enzyme aqualysin i and preparation thereof |